Company Directory - Pharmaco

Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop disease modifying therapeutics in immuno-oncology and immuno-inflammation.

Sun Pharmaceutical Industries Ltd. (Sun Pharma) is the fourth largest specialty generic pharmaceutical company in the world with global revenues of over US$ 4.5 billion. Supported by more than 40 manufacturing facilities, we provide high-quality, affordable medicines, trusted by healthcare professionals and patients, to more than 100 countries across the globe.

The vision of T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments. Despite significant advances of classical therapies, there remains a high need for novel and innovative medicines to treat cancer. T3 Pharmaceuticals is dedicated to filling this gap by developing highly specific and efficient treatments using live bacteria.

TauRx is dedicated to studying neurodegenerative diseases and is at the forefront of Alzheimer’s research. From discovery, through development to clinical trials, regulatory submissions and product registration, we aim to halt the progression of AD.

We are a clinical-stage biopharmaceutical company developing a portfolio of single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and other chronic liver diseases.

Our mission is to be a global leader in generics and biopharmaceuticals, improving the lives of patients across the world. In a complex world, Teva's mission is simple: to improve the lives of patients across the globe. We believe that everyone should have access to quality medicines whether it be for managing disease, fighting infections, or simply improving overall health.

Thermosome is an emerging biopharmaceutical company headquartered in the Innovation and Start-Up Center for Biotechnology (IZB) in Planegg/Martinsried near Munich, Germany. Thermosome is developing drug candidates leveraging its proprietary drug delivery technology, which exploits a novel Mechanism of Action called intravascular drug release.

Tillotts Pharma UK Ltd was established in March 2010. Jeremy Thorpe (Managing Director) joined in July 2012, with a clear focus on optimising the portfolio of gastrointestinal (GI) health products. Tillotts Pharma UK is now a market leader.

Tris Pharma is a privately owned premier specialty pharmaceutical company focused on commercializing our branded portfolio of differentiated ADHD medications, seeking development and licensing partnerships by leveraging our novel technology platform, and growing our niche generics business.

A pharmaceutical manufacturing company which makes a range of prescription and OTC medicines with a focus on dermatology, including wound care, digestive health (gastrointestinal), as well as a range of vitamin E preparations

A global biopharmaceutical company focused on creating value for people living with severe diseases in immunology and neurology, on a journey to become the patient-preferred biopharma leader by delivering medicines and solutions that improve lives.

For over 40 years the name URSAPHARM stands for the consistent transfer of innovative pharmaceutical conceptions into successful medicine and medicinal products. Today URSAPHARM is an international medium-sized concern and due to the large range of products it belongs to the market leaders in Germany in the field of ophthalmology.

United BioSource LLC (UBC) is a leading provider of pharmaceutical support services, partnering with life science companies to make medicine and medical products safer and more accessible.

Urovant Sciences is a biopharmaceutical company focused on developing and commercializing innovative therapies for a range of urologic conditions. Our goal is to be the leading specialty company, recognized and trusted by patients and providers for our commitment to urology.

Vertex is a global biotechnology company that invests in scientific innovation to create medicines for people with serious diseases. The company has three approved medicines in the UK that treat the underlying cause of cystic fibrosis.

Vifor Pharma Group is a global pharmaceuticals company headquartered in Switzerland. It aims to become the global leader in iron deficiency, nephrology and cardio-renal therapies.

We are a biotechnology company focused on delivering transformational therapies for patients with serious, genetically defined diseases. Through the eyes of our world-leading scientists, we see the future of medicine.